Fig. 8From: The survival analysis and oncogenic effects of CFP1 and 14-3-3 expression on gastric cancerSurvival analysis of gastric cancer specimens of lymph node metastasis stage by KM-plot data. a In lymph node metastasis stage N0–N3, the survival time of gastric cancer patients with high expression of CFP1 is shorter than the patients with low expression (P < 0.05). b In lymph node metastasis stage N0–N3, the survival time of gastric cancer patients with high expression of 14-3-3 is longer than the patients with low expression (P < 0.05)Back to article page